These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 11147026)
21. Thoracic presentations of posttransplant lymphoproliferative disorders. Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707 [TBL] [Abstract][Full Text] [Related]
22. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720 [TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case. Shitrit D; Shitrit AB; Dickman R; Sahar G; Saute M; Kramer MR Dis Colon Rectum; 2005 Nov; 48(11):2144-7. PubMed ID: 16086224 [TBL] [Abstract][Full Text] [Related]
24. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children. Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323 [TBL] [Abstract][Full Text] [Related]
25. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965 [TBL] [Abstract][Full Text] [Related]
26. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients. Raj R; Frost AE J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients. Shahinian VB; Muirhead N; Jevnikar AM; Leckie SH; Khakhar AK; Luke PP; Rizkalla KS; Hollomby DJ; House AA Transplantation; 2003 Mar; 75(6):851-6. PubMed ID: 12660514 [TBL] [Abstract][Full Text] [Related]
35. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors. Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ J Heart Lung Transplant; 2015 Nov; 34(11):1406-14. PubMed ID: 26279197 [TBL] [Abstract][Full Text] [Related]
36. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia. Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation. Wigle DA; Chaparro C; Humar A; Hutcheon MA; Chan CK; Keshavjee S Transplantation; 2001 Dec; 72(11):1783-6. PubMed ID: 11740388 [TBL] [Abstract][Full Text] [Related]
38. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR. Michelson P; Watkins B; Webber SA; Wadowsky R; Michaels MG Pediatr Transplant; 2008 Jun; 12(4):464-8. PubMed ID: 18466434 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series. Mendogni P; Henchi S; Morlacchi LC; Tosi D; Nosotti M; Tarsia P; Gregorini AI; Rosso L Transplant Proc; 2019; 51(1):194-197. PubMed ID: 30655153 [TBL] [Abstract][Full Text] [Related]
40. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]